Related Experiment Video

Updated: Oct 14, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.3K

Post-COVID-19 Intestinal and Mesenteric Mucormycosis

Niladri Banerjee1, Mahendra Lodha1, Prathyusha Kompally1

  • 1Department of General Surgery, All India Institute of Medical Sciences, Jodhpur, India.

The American Surgeon
|November 3, 2021
PubMed

Insights

A post-COVID-19 patient with uncontrolled diabetes developed severe intestinal mucormycosis. This rare opportunistic infection highlights the risks associated with weakened immunity following COVID-19 and diabetes management.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Mucormycosis is a rare, life-threatening fungal infection.
  • Gastrointestinal mucormycosis is particularly uncommon.
  • Recent COVID-19 infection can lead to immunosuppression.

Purpose of the Study:

  • To report an unusual case of extensive gastrointestinal mucormycosis.
  • To investigate the potential link between COVID-19 and mucormycosis.
  • To highlight risk factors for opportunistic infections post-COVID-19.

Main Methods:

  • Case report of a 38-year-old male patient.
  • Microscopic diagnosis of intestinal and mesenteric mucormycosis.
  • Review of patient's medical history including uncontrolled diabetes and recent COVID-19 infection.

Main Results:

  • The patient presented with extensive bowel ischemia and gangrene.
  • Microscopic examination confirmed mucormycosis affecting the intestine and mesentery.
  • The infection occurred in the context of uncontrolled diabetes and recent COVID-19.

Conclusions:

  • Uncontrolled diabetes and COVID-19-induced immunosuppression are likely contributors to mucormycosis.
  • Gastrointestinal mucormycosis is a rare but severe complication in immunocompromised patients.
  • This case underscores the importance of monitoring for opportunistic infections post-COVID-19, especially in diabetic patients.
Keywords:
COVID-19gastrointestinalmucormycosisopportunistic infections in COVID

More Related Videos

Multimodality Diagnosis of Mesenteric Ischemia05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

809
Murine Ileocolic Bowel Resection with Primary Anastomosis08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.7K

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
273
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
178
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
175
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
451